Philipp Schubert

Medizinische Fakultät

Protocol-based CT-guided brachytherapy for patients with prostate cancer and previous rectal extirpation—a curative approach (2025) Schubert P, Strnad V, Weissmann T, Schweizer C, Lotter M, Kreppner S, Karius A, et al. Journal article Reirradiation for recurrent glioblastoma: the significance of the residual tumor volume (2025) Mansoorian S, Schmidt M, Weissmann T, Delev D, Heiland DH, Coras R, Stritzelberger J, et al. Journal article Safety and Efficacy of Brachytherapy in Inoperable Endometrial Cancer (2024) Merten R, Strnad V, Schweizer C, Lotter M, Kreppner S, Fietkau R, Schubert P, et al. Journal article The Segment Anything foundation model achieves favorable brain tumor auto-segmentation accuracy in MRI to support radiotherapy treatment planning (2024) Putz F, Beirami S, Schmidt M, May M, Grigo J, Weissmann T, Schubert P, et al. Journal article, Original article Brachytherapy in vaginal cancer for organ preservation: Clinical outcome and safety from a single center experience (2024) Merten R, Strnad V, Karius A, Lotter M, Kreppner S, Schweizer C, Fietkau R, Schubert P Journal article Principles of artificial intelligence in radiooncology (2024) Huang Y, Gomaa A, Höfler D, Schubert P, Gaipl U, Frey B, Fietkau R, et al. Journal article, Original article Outcomes of I-125 Low-Dose-Rate Brachytherapy in Patients with Localized Prostate Cancer: A Comprehensive Analysis from a Specialized Tertiary Referral Center (2024) Schubert P, Strnad V, Höfler D, Schweizer C, Putz F, Lotter M, Kreppner S, et al. Journal article Optimized raw data selection for artifact reduction of breathing controlled four-dimensional sequence scanning (2024) Szkitsak J, Karius A, Fernolendt S, Schubert P, Speer S, Fietkau R, Bert C, Hofmann C Journal article Definitive treatment for primary urethral cancer: A single institution's experience with organ-preserving brachytherapy (2024) Merten R, Strnad V, Karius A, Lotter M, Kreppner S, Schweizer C, Fietkau R, Schubert P Journal article De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status—results of a prospective multicenter phase II trial (DIREKHT Trial) (2024) Haderlein M, von der Grün J, Balermpas P, Rödel C, Hautmann MG, Steger F, Bohr C, et al. Journal article